Latest News

 Filter by Provider

It may be time to stop ignoring this overlooked cybersecurity stock.

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

A pseudonymous trader has shared a story of turning one of the market's worst wipeouts into an inspiring comeback by recovering from a $400,000 loss with narrative-driven spot investing.

BitMine Immersion Technologies Inc (AMEX:BMNR) shares are bouncing around in early trading Tuesday after the company announced a shelf offering by selling stockholders and a subsequent

The Procter & Gamble Company reported its latest quarterly earnings.

AstraZeneca posted $14.46 billion in Q2 revenue, reaffirming its 2025 outlook as the FDA advances Imfinzi in gastric cancer.

U.S. Commerce Secretary Howard Lutnick said Trump is likely to announce a new policy targeting drug manufacturing within the next two weeks, and pharmaceuticals not made in the U.S. could face ‘massive’ tariffs.

She's in a solid financial position, but there are still lots of unknowns.

Norfolk Southern Corp (NYSE:NSC) reported financial results for the second quarter ahead of the market open on Tuesday. Here's a look at the key metrics from the quarter.

UnitedHealth's Q2 earnings and revenue fell short of estimates as medical costs surged. Full-year 2025 outlook was revised sharply lower.

The short-covering recovery in the US dollar has been extended today but the momentum stalled in the European morning.

SoFi reported second-quarter revenue of $858.23 million, beating analyst estimates of $801.49 million, according to Benzinga Pro. The company reported second-quarter adjusted earnings of 8 cents per share, beating estimates of 6 cents per share.

On Semiconductor collaborates with Nvidia on 800 Volt DC power solutions to improve efficiency and support next-gen AI data centers. ON stock gains despite 7% YTD dip and US-China tech export restrictions.On Semiconductor collaborates with Nvidia to advance 800 Volt DC power solutions for AI data centers. ON stock up 3.93% despite 7% YTD dip and US-China trade tensions.

PayPal reports strong Q2 results, beats analyst estimates, raises full-year guidance. Stock drops 8% YTD, grapples with competition and market conditions.

Novo Nordisk lowered its full-year guidance and named a new CEO. The pharma giant's shares plunged in early trades.

It’s a busy week in terms of potentially market moving announcements, with a slew of important economic data and big corporate earnings reports due over the coming days.

Although free cash flow decreased and expenses rose, the company continued to reduce its share count and raised its full-year guidance.

CrowdStrike stock is climbing on AI-driven momentum, and bullish options activity suggests investors are optimistic ahead of its upcoming earnings

According to Ambience co-founder and CEO Mike Ng, the new capital would help expand the depth and breadth of the platform, with a focus on strengthening its partnership with OpenAI to build advanced healthcare-specific foundation models.

Franklin Electric (FELE) Q2 2025 earnings beat revenue estimates but missed EPS slightly, sparking a 7.6% pre-market drop amid investor concerns over guidance and margins.

Warren Buffett is not invested in any pure-play AI companies, but he holds these five stocks via Berkshire, which leverage AI.

Nvidia's CEO has sold millions of dollars worth of his company's shares this year, and he's not done selling yet.

Sysco Corp (NYSE:SYY) reported mixed Q4 2025 results, missing revenue estimates but beating EPS. Shares dipped slightly pre-market. Analysts eye fiscal 2026 guidance.

The lack of a trade agreement between the United States and China could lead to a significant drop in Chinese exports to the U.S., a new report suggests.

Exagen Inc (XGN) beats Q2 2025 revenue estimates with $17.2M but posts wider loss. Stock jumps 6.77% pre-market as investors focus on growth potential.

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring initiative.

Camden National Corp (CAC) reported mixed Q2 2025 results, with revenue beating estimates but EPS missing. Net income surged 92%, sparking a 2.97% pre-market gain. Analysts eye future margin trends.

NexPoint Residential Trust (NXRT) beat Q2 2025 EPS estimates with $0.80 vs. -$0.34 expected, though revenue slightly missed. Shares rose 5.27% pre-market, driven by strong profitability and a $0.51 dividend.

Taiwan's semiconductor industry faces a talent deficit of 34,000 workers, posing a challenge to its dominant position in the global supply chain. With rapid industry expansion and demographic trends, the country must invest in skilled personnel to sustain growth.

AstraZeneca's share price held steady this week after the company published strong financial results on Tuesday.

UPS posted Q2 results that beat revenue expectations but narrowly missed earnings estimate, citing global trade complexities. Stock down 5%.

The $3 billion will be reinvested to support new product launches and its pipeline across multiple therapeutic areas, Merck said.

Ark Invest bought into some of its leaders and laggards on Monday.

The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted access.

The EUR/USD outlook turns negative as the Eurozone is hit by the US-EU trade deal.

Microsoft and Meta are scheduled to report their earnings on Wednesday, alongside Arm Holdings and Qualcomm. Apple and Amazon’s quarterly results are scheduled to be announced on Thursday.